Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 6319

1.

Neoplastic transformation of peribiliary stem cell niche in cholangiocarcinoma arisen in primary sclerosing cholangitis.

Carpino G, Cardinale V, Folseraas T, Overi D, Grzyb K, Costantini D, Berloco PB, Di Matteo S, Karlsen TH, Alvaro D, Gaudio E.

Hepatology. 2018 Aug 13. doi: 10.1002/hep.30210. [Epub ahead of print]

PMID:
30102768
2.

Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.

Lemoinne S, Pares A, Reig A, Ben Belkacem K, Kemgang Fankem AD, Gaouar F, Poupon R, Housset C, Corpechot C, Chazouillères O.

Clin Res Hepatol Gastroenterol. 2018 Aug 9. pii: S2210-7401(18)30121-9. doi: 10.1016/j.clinre.2018.06.009. [Epub ahead of print]

PMID:
30100231
3.

Incidence and clinical features of autoimmune hepatitis in the province of santa fe (Argentina).

Costaguta AC, González A, Pochettino S, Trotta L, Vicentín R, Wagener M.

J Pediatr Gastroenterol Nutr. 2018 Aug 8. doi: 10.1097/MPG.0000000000002122. [Epub ahead of print]

PMID:
30095578
4.

Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease.

Chung BK, Henriksen EKK, Jørgensen KK, Karlsen TH, Hirschfield GM, Liaskou E.

Hepatol Commun. 2018 Aug 6;2(8):956-967. doi: 10.1002/hep4.1200. eCollection 2018 Aug.

5.

Effects of human amnion-derived mesenchymal stem cells and conditioned medium in rats with sclerosing cholangitis.

Sugiura R, Ohnishi S, Ohara M, Ishikawa M, Miyamoto S, Onishi R, Yamamoto K, Kawakubo K, Kuwatani M, Sakamoto N.

Am J Transl Res. 2018 Jul 15;10(7):2102-2114. eCollection 2018.

6.

Post-Transplant Disease Recurrence in Pediatric PSC.

Soufi N, Bazerbachi F, Deneau M.

Curr Gastroenterol Rep. 2018 Aug 6;20(9):44. doi: 10.1007/s11894-018-0649-2. Review.

PMID:
30083892
7.

[Neonatal sclerosing cholangitis caused by DCDC2 variations in two siblings and literature review].

Li JQ, Lu Y, Qiu YL, Wang JS.

Zhonghua Er Ke Za Zhi. 2018 Aug 2;56(8):623-627. doi: 10.3760/cma.j.issn.0578-1310.2018.08.013. Chinese.

PMID:
30078246
8.

Systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease.

Belle A, Laurent V, Pouillon L, Baumann C, Orry X, Lopez A, Rousseau H, Bronowicki JP, Peyrin-Biroulet L.

Dig Liver Dis. 2018 Jul 31. pii: S1590-8658(18)30813-2. doi: 10.1016/j.dld.2018.06.024. [Epub ahead of print]

PMID:
30076016
9.

Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.

Buchholz BM, Lykoudis PM, Ravikumar R, Pollok JM, Fusai GK.

World J Gastroenterol. 2018 Jul 28;24(28):3171-3180. doi: 10.3748/wjg.v24.i28.3171.

10.

Liver Transplant in Patients with Primary Sclerosing Cholangitis: Long-Term Experience of a Single Center.

Astarcioglu I, Egeli T, Unek T, Akarsu M, Sagol O, Obuz F, Ozbilgin M, Aysal Agalar A, Ağalar C.

Exp Clin Transplant. 2018 Aug;16(4):434-438.

11.

Massive hemobilia following plastic stent removal in common bile duct cancer associated with primary sclerosing cholangitis (with video).

Miyamoto H, Tanaka K, Nakamura F, Ikeda T, Kitamura S, Kimura T, Okamoto K, Sogabe M, Muguruma N, Bando Y, Takayama T.

Clin J Gastroenterol. 2018 Jul 28. doi: 10.1007/s12328-018-0888-7. [Epub ahead of print]

PMID:
30056613
12.

Clinical and molecular features of X-linked hyper IgM syndrome - An experience from North India.

Rawat A, Mathew B, Pandiarajan V, Jindal A, Sharma M, Suri D, Gupta A, Goel S, Karim A, Saikia B, Minz RW, Imai K, Nonoyama S, Ohara O, Giliani SC, Notarangelo LD, Chan KW, Lau YL, Singh S.

Clin Immunol. 2018 Jul 25;195:59-66. doi: 10.1016/j.clim.2018.07.013. [Epub ahead of print]

PMID:
30053428
13.

Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis.

de Chambrun GP, Nachury M, Funakoshi N, Gerard R, Bismuth M, Valats JC, Panaro F, Navarro F, Desreumaux P, Pariente B, Blanc P.

Eur J Gastroenterol Hepatol. 2018 Jul 26. doi: 10.1097/MEG.0000000000001223. [Epub ahead of print]

PMID:
30052539
14.

The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitis.

Jhaveri KS, Hosseini-Nik H, Sadoughi N, Janssen H, Feld JJ, Fischer S, Menezes R, Cheung AC.

Eur Radiol. 2018 Jul 26. doi: 10.1007/s00330-018-5619-4. [Epub ahead of print]

PMID:
30051141
15.

Advances in IgG4-related pancreatobiliary diseases.

Kamisawa T, Zen Y, Nakazawa T, Okazaki K.

Lancet Gastroenterol Hepatol. 2018 Aug;3(8):575-585. doi: 10.1016/S2468-1253(18)30121-3. Review.

PMID:
30047448
16.

The case for combining treatments for primary sclerosing cholangitis.

Roscam Abbing RLP, de Lannoy LM, van de Graaf SFJ.

Lancet Gastroenterol Hepatol. 2018 Aug;3(8):526-528. doi: 10.1016/S2468-1253(18)30173-0. No abstract available.

PMID:
30047442
17.

Immunoglobulin G4-related sclerosing cholangitis.

Goodchild G, Pereira SP, Webster G.

Korean J Intern Med. 2018 Jul 27. doi: 10.3904/kjim.2018.018. [Epub ahead of print]

18.

Long-Term outcomes of primary sclerosing cholangitis: an australian Non-Transplant tertiary hospital perspective.

Freeman E, Majeed A, Kemp W, Roberts SK.

Intern Med J. 2018 Jul 24. doi: 10.1111/imj.14041. [Epub ahead of print]

PMID:
30043518
19.

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Sundaram S, S K, Mazumdar S, Shukla A.

ACG Case Rep J. 2018 Jul 18;5:e54. doi: 10.14309/crj.2018.54. eCollection 2018.

20.

Anti-Programmed Cell Death-1 Immunotherapy-Related Secondary Sclerosing Cholangitis.

Ogawa K, Kamimura K, Terai S.

Hepatology. 2018 Jul 23. doi: 10.1002/hep.30189. [Epub ahead of print]

PMID:
30033637

Supplemental Content

Loading ...
Support Center